1. 1. Baral N, Koner BC, Karki P, Ramaprasad C, Lamsal M, Koirala S. Evaluation of new WHO diagnostic criteria for diabetes on the prevalence of abnormal glucose tolerance in a heterogeneous Nepali population-the implications of measuring glycated hemoglobin. Singapore Med J 2000 Jun; 41(6):264-7.
2. Babes Elena Emilia and Babes Victor Vlad. University Oradea, Faculty of Medicine and Pharmacy Romania. Detection of Silent Ischemia in Patients with Type 2 Diabetes. Recent Advances in the Pathogenesis, Prevention and Management of Type 2 Diabetes and its Complications. Chapter 9. DOI: 10.5772/21949.
3. Haffner SM. Coronary heart disease in patients with diabetes. N Engl J Med 2000; 342: 1040-1042.
4. Cryer PE. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2007; 30:190-2.
5. Fox CS, Coady S, Sorlie PD. Trends in cardiovascular complications of diabetes. JAMA 2004; 292: 2495-2499.
6. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's Principles of Internal medicine. New York: McGraw-Hill Medical Publishing Division, 17thed, 2008; vol 2.1365:1581.
7. Young LH, Chyun DA: Heart disease in patients with diabetes. In Ellenberg and Rifkin’s Diabetes Mellitus: Theory and Practice. 6th ed. Porte DJ, Baron A, Sherwin RS, Eds. New York, McGraw-Hill, 2002, p. 823–844.
8. Nesto RW, Phillips RT, Kett KG, et al. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med 1988; 108:170–5.
9. Rutter et al. Significance of Silent Ischemia and Microalbuminuria in Predicting Coronary Events in Asymptomatic Patients with Type 2 Diabetes. Journal of the American College of Cardiology 2002; vol. 40, No. 1.
10. Janand-Delenne B, Savin B, Habib G, et al. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care1999; 22:1396-400.
11. Cosson E, Guimfack M, Paries J, et al.Are silent coronary stenosis predictable in diabetic patients and predictive of cardiovascular events? Diabetes Metab 2003; 29:470-6.
12. Nesto RW, Watson FS, Kowalchuk GJ, et al. Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment by dipyridamole thallium-201 scintigraphy. Am Heart J 1990; 120:1073-7.
13. Doobay AV, Anand SS. Sensitivity and specificity of the ankleebrachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol 2005; 25:1463-9.
14. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation 2006; 114:688-99.
15. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295:180-9.
|